Adjuvant effect of a natural TLR4 ligand on dendritic cell-based cancer immunotherapy

Cancer Letters

Volumn 313, Issue 2, 2011, Pages 226-234

  Kim, Jee Youn ^a   Kim, Yeon Jin ^a   Kim, Ji Sung ^a   Ryu, Hwa Sun ^a   Lee, Hong Kyung ^a   Kang, Jong Soon ^b   Kim, Hwan Mook ^c   Hong, Jin Tae ^a   Kim, Youngsoo ^a   Han, Sang Bae ^a  

^a Chungbuk National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Gachon University College of Medicine   (South Korea)

Author keywords

Angelan; Dendritic cells; Maturation; Migration; TLR4 ligand

Indexed keywords

ANGELAN; B7 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; DENDRITIC CELL VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYSACCHARIDE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL HOMING; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG POTENTIATION; EX VIVO STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; MELANOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; CANCER VACCINES; CELL MOVEMENT; CHEMOKINE CCL19; CHEMOKINE CXCL12; DENDRITIC CELLS; FEMALE; IMMUNOTHERAPY; LYMPH NODES; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS; NF-KAPPA B; POLYSACCHARIDES; RECEPTORS, CCR7; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 82655181794     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.09.009     Document Type: Article

References (47)

1. Alvarez D., Vollmann E.H., von Andrian U.H. Mechanisms and consequences of dendritic cell migration. Immunity 2008, 29:325-342.
2. Gao J.Q., Okada N., Mayumi T., Nakagawa S. Immune cell recruitment and cell-based system for cancer therapy. Pharm. Res. 2008, 25:752-768.
3. Hovden A.O., Appel S. The first dendritic cell-based therapeutic cancer vaccine is approved by the FDA. Scand. J. Immunol. 2010, 72:554.
4. Bennaceur K., Chapman J., Brikci-Nigassa L., Sanhadji K., Touraine J.L., Portoukalian J. Dendritic cells dysfunction in tumour environment. Cancer Lett. 2008, 272:186-196.
5. Kusmartsev S., Gabrilovich D.I. Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer. Cancer Metast. Rev. 2006, 25:323-331.
6. Nefedova Y., Huang M., Kusmartsev S., Bhattacharya R., Cheng P., Salup R., Jove R., Gabrilovich D. Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. J. Immunol. 2004, 172:464-474.
7. Rabinovich G.A., Gabrilovich D., Sotomayor E.M. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 2007, 25:267-296.
8. Verdijk P., Aarntzen E.H., Punt C.J., de Vries I.J., Figdor C.G. Maximizing dendritic cell migration in cancer immunotherapy. Expert Opin. Biol. Ther. 2008, 8:865-874.
9. Han S.B., Kim Y.H., Lee C.W., Park S.M., Lee H.Y., Ahn K.S., Kim I.H., Kim H.M. Characteristic immunostimulation by angelan isolated from Angelica gigas Nakai. Immunopharmacology 1998, 40:39-48.
10. Han S.B., Lee C.W., Kang M.R., Yoon Y.D., Kang J.S., Lee K.H., Yoon W.K., Lee K., Park S.K., Kim H.M. Pectic polysaccharide isolated from Angelica gigas Nakai inhibits melanoma cell metastasis and growth by directly preventing cell adhesion and activating host immune functions. Cancer Lett. 2006, 243:264-273.
11. Jeon Y.J., Han S.B., Ahn K.S., Kim H.M. Activation of NF-kappaB/Rel in angelan-stimulated macrophages. Immunopharmacology 1999, 43:1-9.
12. Jeon Y.J., Han S.B., Ahn K.S., Kim H.M. Differential activation of murine macrophages by angelan and LPS. Immunopharmacology 2000, 49:275-284.
13. Jeon Y.J., Han S.B., Lee S.H., Kim H.C., Ahn K.S., Kim H.M. Activation of mitogen-activated protein kinase pathways by angelan in murine macrophages. Int. Immunopharmacol 2001, 1:237-245.
14. Kim J.Y., Yoon Y.D., Ahn J.M., Kang J.S., Park S.K., Lee K., Song K.B., Kim H.M., Han S.B. Angelan isolated from Angelica gigas Nakai induces dendritic cell maturation through toll-like receptor 4. Int. Immunopharmacol 2007, 7:78-87.
15. Kim H.S., Kim J.Y., Ryu H.S., Park H.G., Kim Y.O., Kang J.S., Kim H.M., Hong J.T., Kim Y., Han S.B. Induction of dendritic cell maturation by beta-glucan isolated from Sparassis crispa. Int. Immunopharmacol 2010, 10:1284-1294.
16. Kim J.Y., Kang J.S., Kim H.M., Ryu H.S., Kim H.S., Lee H.K., Kim Y.J., Hong J.T., Kim Y., Han S.B. Inhibition of bone marrow-derived dendritic cell maturation by glabridin. Int. Immunopharmacol 2010, 10:1185-1193.
17. Kim H.S., Kim J.Y., Kang J.S., Kim H.M., Kim Y.O., Hong I.P., Lee M.K., Hong J.T., Kim Y., Han S.B. Cordlan polysaccharide isolated from mushroom Cordyceps militaris induces dendritic cell maturation through toll-like receptor 4 signalings. Food Chem. Toxicol. 2010, 48:1926-1933.
18. Han S.B., Moratz C., Huang N.N., Kelsall B., Cho H., Shi C.S., Schwartz O., Kehrl J.H. Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. Immunity 2005, 22:343-354.
19. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
20. Palucka K., Ueno H., Roberts L., Fay J., Banchereau J. Dendritic cells: are they clinically relevant?. Cancer J. 2010, 16:318-324.
21. Cao T., Ueno H., Glaser C., Fay J.W., Palucka A.K., Banchereau J. Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL. Eur. J. Immunol. 2007, 37:2657-2667.
22. Neidhardt-Berard E.M., Berard F., Banchereau J., Palucka A.K. Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes. Breast Cancer Res 2004, 6:R322-328.
23. Nouri-Shirazi M., Banchereau J., Bell D., Burkeholder S., Kraus E.T., Davoust J., Palucka K.A. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J. Immunol. 2000, 165:3797-3803.
24. Saito H., Dubsky P., Dantin C., Finn O.J., Banchereau J., Palucka A.K. Cross-priming of cyclin B1, MUC-1 and survivin-specific CD8 + T cells by dendritic cells loaded with killed allogeneic breast cancer cells. Breast Cancer Res. 2006, 8:R65.
25. van de Laar L., van den Bosch A., van der Kooij S.W., Janssen H.L., Coffer P.J., van Kooten C., Woltman A.M. A nonredundant role for canonical NF-kappaB in human myeloid dendritic cell development and function. J. Immunol. 2010, 185:7252-7261.
26. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
27. Henkel T., Machleidt T., Alkalay I., Kronke M., Ben-Neriah Y., Baeuerle P.A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 1993, 365:182-185.
28. Ha K.H., Byun M.S., Choi J., Jeong J., Lee K.J., Jue D.M. N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65/RelA. Biochemistry 2009, 48:7271-7278.
29. Shinoda K., Nakagawa K., Kosaka T., Tanaka N., Maeda T., Kono H., Mizuno R., Kikuchi E., Miyajima A., Umezawa K., Oya M. Regulation of human dendritic cells by a novel specific nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin. Hum. Immunol. 2010, 71:763-770.
30. Rescigno M., Martino M., Sutherland C.L., Gold M.R., Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 1998, 188:2175-2180.
31. Yamagami S., Yokoo S., Usui T., Yamagami H., Amano S., Ebihara N. Distinct populations of dendritic cells in the normal human donor corneal epithelium. Invest. Ophthalmol. Vis. Sci. 2005, 46:4489-4494.
32. Sallusto F., Schaerli P., Loetscher P., Schaniel C., Lenig D., Mackay C.R., Qin S., Lanzavecchia A. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 1998, 28:2760-2769.
33. MartIn-Fontecha A., Sebastiani S., Hopken U.E., Uguccioni M., Lipp M., Lanzavecchia A., Sallusto F. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 2003, 198:615-621.
34. Chen X., Murakami T., Oppenheim J.J., Howard O.M. Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking. Blood 2005, 106:2409-2416.
35. Hinz M., Lemke P., Anagnostopoulos I., Hacker C., Krappmann D., Mathas S., Dorken B., Zenke M., Stein H., Scheidereit C. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J. Exp. Med. 2002, 196:605-617.
36. Harding F.A., McArthur J.G., Gross J.A., Raulet D.H., Allison J.P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992, 356:607-609.
37. Gabrilovich D.I., Nadaf S., Corak J., Berzofsky J.A., Carbone D.P. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. Cell Immunol. 1996, 170:111-119.
38. Menetrier-Caux C., Montmain G., Dieu M.C., Bain C., Favrot M.C., Caux C., Blay J.Y. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 1998, 92:4778-4791.
39. Shurin G.V., Shurin M.R., Bykovskaia S., Shogan J., Lotze M.T., Barksdale E.M. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res. 2001, 61:363-369.
40. Manome H., Aiba S., Tagami H. Simple chemicals can induce maturation and apoptosis of dendritic cells. Immunology 1999, 98:481-490.
41. Dourado F., Madureira P., Carvalho V., Coelho R., Coimbra M.A., Vilanova M., Mota M., Gama F.M. Purification, structure and immunobiological activity of an arabinan-rich pectic polysaccharide from the cell walls of Prunus dulcis seeds. Carbohydr. Res. 2004, 339:2555-2566.
42. Lehner M.D., Morath S., Michelsen K.S., Schumann R.R., Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J. Immunol. 2001, 166:5161-5167.
43. Kanazawa M., Mori Y., Yoshihara K., Iwadate M., Suzuki S., Endoh Y., Ohki S., Takita K., Sekikawa K., Takenoshita S. Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes. Immunol. Lett. 2004, 91:229-238.
44. Kim G.Y., Han M.G., Song Y.S., Shin B.C., Shin Y.I., Lee H.J., Moon D.O., Lee C.M., Kwak J.Y., Bae Y.S., Lee J.D., Park Y.M. Proteoglycan isolated from Phellinus linteus induces toll-like receptors 2- and 4-mediated maturation of murine dendritic cells via activation of ERK, p38, and NF-kappaB. Biol. Pharm. Bull. 2004, 27:1656-1662.
45. Kim G.Y., Lee M.Y., Lee H.J., Moon D.O., Lee C.M., Jin C.Y., Choi Y.H., Jeong Y.K., Chung K.T., Lee J.Y., Choi I.H., Park Y.M. Effect of water-soluble proteoglycan isolated from Agaricus blazei on the maturation of murine bone marrow-derived dendritic cells. Int. Immunopharmacol. 2005, 5:1523-1532.
46. Lee J.K., Lee M.K., Yun Y.P., Kim Y., Kim J.S., Kim Y.S., Kim K., Han S.S., Lee C.K. Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells. Int Immunopharmacol. 2001, 1:1275-1284.
47. Masuda Y., Ito K., Konishi M., Nanba H. A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer. Cancer Immunol. Immunother. 2010, 59:1531-1541.